Clinical Trial Update: Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients [Phase 4]

View source ↗

Summary

Phase 4 safety study comparing Kedbumin 25% to normal saline in pediatric post-surgical hypovolemia was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypovolemia

Drugs mentioned

• Kedbumin 25% (Kedbumin)
• Normal Saline (sodium chloride 0.9% solution)

Snippet

Sponsor: Kedrion S.p.A. | Conditions: Hypovolemia | Phase 4 | Status: TERMINATED | Results posted: 2021-02-18